[HTML][HTML] Herpesvirus respiratory infections in immunocompromised patients: epidemiology, management, and outcomes

GE Reid, JP Lynch III, S Weigt, D Sayah… - … in respiratory and …, 2016 - thieme-connect.com
GE Reid, JP Lynch III, S Weigt, D Sayah, JA Belperio, SA Grim, NM Clark
Seminars in respiratory and critical care medicine, 2016thieme-connect.com
Among immunocompromised individuals, members of the human Herpesviridae family are
frequently encountered pathogens. Cytomegalovirus, herpes simplex virus 1 and 2, varicella
zoster virus, Epstein–Barr virus, and human herpesvirus-6,-7, and-8 all establish latency
after infection and can reactivate during periods of immunosuppression, leading to both
direct and indirect adverse effects on the host including severe organ dysfunction as well as
allograft rejection and loss after transplantation. While not all herpesviruses are primary …
Among immunocompromised individuals, members of the human Herpesviridae family are frequently encountered pathogens. Cytomegalovirus, herpes simplex virus 1 and 2, varicella zoster virus, Epstein–Barr virus, and human herpesvirus-6, -7, and -8 all establish latency after infection and can reactivate during periods of immunosuppression, leading to both direct and indirect adverse effects on the host including severe organ dysfunction as well as allograft rejection and loss after transplantation. While not all herpesviruses are primary respiratory pathogens, many of their manifestations include involvement of the respiratory tract. This article discusses the individual viruses, their epidemiology, and clinical manifestations as well as recommended treatment and preventive strategies.
Thieme Connect